Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousWhole-Body IrradiationBone and BonesSyndromeAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLeukemiaLiver TransplantationTransplantation ChimeraTissue DonorsGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHematopoietic Stem CellsHistocompatibilityCyclophosphamideTransplantation, IsogeneicBone Marrow DiseasesKidney TransplantationRecurrenceHematopoiesisCombined Modality TherapyTreatment OutcomeMice, Inbred C57BLRadiation ChimeraBone Marrow ExaminationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveTime FactorsLeukemia, Myeloid, AcuteImmunosuppressive AgentsRemission InductionHematologic NeoplasmsGraft RejectionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingMyelodysplastic SyndromesAcute DiseaseBone Marrow NeoplasmsRetrospective StudiesLeukemia, MyeloidTransplantation ImmunologyGraft vs Host ReactionImmunosuppressionLymphoma, Non-HodgkinStem Cell TransplantationLymphocyte DepletionHeart TransplantationLeukocyte TransfusionSurvival AnalysisSevere Combined ImmunodeficiencyT-LymphocytesChimeraColony-Forming Units AssayHLA AntigensLung TransplantationFollow-Up StudiesHematologic DiseasesCyclosporineActuarial AnalysisBone DensityLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsNuclear FamilySurvival RatePancytopeniaCarmustineOrgan TransplantationFatal OutcomeLeukocyte CountCell DifferentiationGraft vs Tumor EffectCytarabineCytomegalovirus InfectionsGraft vs Leukemia EffectPrognosisSpleenBone ResorptionGranulocyte Colony-Stimulating FactorDisease-Free SurvivalMelphalanMice, Inbred BALB CLymphomaFlow CytometryEtoposideMultiple MyelomaCells, CulturedProspective StudiesHodgkin DiseaseMice, KnockoutInfectionImmunologic Deficiency SyndromesAntigens, CD34